Clinical Trials Logo

Pharmacist-Patient Relations clinical trials

View clinical trials related to Pharmacist-Patient Relations.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06029842 Completed - Clinical trials for Pharmacist-Patient Relations

The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan

Start date: October 17, 2022
Phase: N/A
Study type: Interventional

This study aimed to assess the impact of the clinical pharmacist on enhancing type 2 diabetic patients outcomes in a primary health care center.

NCT ID: NCT05580757 Completed - Suicide Clinical Trials

Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists

Start date: September 2, 2022
Phase:
Study type: Observational

This study aims to examine the opinions and needs of pharmacists and pharmaceutical technical assistants (FTA) concerning their role as gatekeepers in suicide prevention. The primary objective is to map the experiences and needs of (public) pharmacists and FTA with regard to suicide prevention. The secondary objective is to be able to develop more targeted tools, interventions or trainings based on the results of the needs assessment in order to facilitate the role of (public) pharmacists and FTA as gatekeepers in suicide prevention.

NCT ID: NCT05461066 Completed - Smoking Cessation Clinical Trials

Cost-effectiveness of a Tobacco Cessation Care Service in the Community Pharmacy

CESAR
Start date: January 1, 2016
Phase: N/A
Study type: Interventional

The study was a non-randomized controlled trial of 12-months' follow-up with 182 Spanish community pharmacists. Intervention community pharmacists received the CESAR training to improve their smoking cessation services, consisting of an initial interview and follow-up visits to identify obstacles and reinforce behaviours. The control group received the usual care. Data were self-reported and collected in a computerized health registration system. Outcomes were smoking cessation and quality of life (EuroQOL-5D) collected at baseline, 6 months', and 12 months' follow-up. Cost data were collected for the study period and included direct health costs, sick leave, and intervention costs. Smoking cessation was analysed through logistic regression models. Generalized linear models were carried out for quality-adjusted life year costs. Incremental cost-effectiveness ratios (ICERs) and cost-utility ratios (RCUI) were calculated. Sensitivity analyses were performed.

NCT ID: NCT05416892 Completed - Clinical trials for Pharmacist-Patient Relations

What is the Impact of Implementing Pharmaceutical Algorithms in the PharmaClass® Software, on the Handling the Patient's Medication Load, by the Clinical Pharmacist?

Start date: September 14, 2021
Phase:
Study type: Observational

The clinical pharmacists present in the hospitalisation units aim to ensure the daily review of the drug prescriptions of hospitalized patients. In order to optimize their work, the objective of this study would be to provide them with a clinical decision support tool via artificial intelligence in order to improve the patient's medication management. This study will test the Pharmaclass® software.

NCT ID: NCT05252221 Completed - Clinical trials for Alcohol Use Disorder (AUD)

Alcohol Telemedicine Consultation in Primary Care (ATC)

ATC
Start date: September 14, 2021
Phase: N/A
Study type: Interventional

This pragmatic, cluster-randomized trial in adult primary care clinics in a healthcare system with a diverse membership will examine the effectiveness of an innovative, multi-faceted intervention, the Addiction Telemedicine Consultant (ATC) service using clinical pharmacists to facilitate alcohol use problems and alcohol use disorder (AUD) pharmacotherapy and specialty addiction treatment entry.